Rahmathullah S.N.: Key Takeaways on Successful Surgical Outcomes in Patients with Congenital Bleeding Disorders
Rahmathullah S.N., Clinical Pharmacist at IQRAA International Hospital and Research Centre, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Indian Journal of Hematology and Blood Transfusion, adding:
”Delighted to share our latest publication in the Indian Journal of Hematology and Blood Transfusion (Springer) titled ‘Achieving Successful Surgical Outcomes in Patients with Congenital Bleeding Disorders: Experience from a Resource-Limited Setting.’
This work details a retrospective study of surgical procedures in patients with congenital bleeding disorders, such as Hemophilia, at a tertiary care center in South India.
Key takeaways include:
- Individualized perioperative planning enables patients with Hemophilia and other clotting factor deficiencies to safely undergo invasive surgeries.
- In Hemophilia A, Emicizumab prophylaxis significantly reduced the requirements for factor VIII and bypassing agents during surgery.
- Success in resource-limited settings depends on multidisciplinary coordination and pragmatic resource utilization.
I am deeply grateful to my mentor, senior hemato-oncologist Dr. Raghuveer Prabhu, whose guidance was crucial to this study, and to Dr. Javed Ahammad, for his dedicated expertise.
Thanks also to my co-author Dr. Henna Pokka and the entire clinical team at IQRAA International Hospital and Research Centre for their commitment to patient care.
We hope this work adds to the evidence base from India and supports clinicians facing similar challenges in resource-constrained environments globally.”
Title: Achieving Successful Surgical Outcomes in Patients with Congenital Bleeding Disorders: Experience from a Resource-Limited Setting
Authors: Henna Pokka, Raghuveer S. Prabhu, S. N. Rahmathullah, Javed Ahammad

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH
-
Oct 16, 2026, 10:07Habib Bennaceur: Building a Stronger Care Pathway for Sickle Cell Disease in India
-
Oct 16, 2026, 09:59Tareq Abadl: A Simple Guide to Blood Collection Tubes
-
Oct 16, 2026, 09:50Mona Alfaraj: Distinguishing HCL from SMZL in Bone Marrow